Poor outcome neutropenic enterocolitis after treatment with docetaxel in a breast cancer patient

被引：0
|
作者：
Cubo, T. [1 ]
Padilla, D. [1 ]
Villarejo, P. [1 ]
Lopez, A. [1 ]
Delgado, M. [2 ]
Menendez, P. [1 ]
机构：
[1] Hosp Gen Ciudad Real, Serv Cirugia Gen & Aparato Digest, Ciudad Real, Spain
[2] Hosp Gen Ciudad Real, Serv Anat Patol, Ciudad Real, Spain
来源：
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS | 2007年 / 99卷 / 08期
关键词：
Neutropenic enterocolitis; Docetaxel; Taxotere; Cytotoxic treatment;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：480 / 482
页数：3
相关论文
共 50 条
  • [41] Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study
    J. Bonneterre
    M. Campone
    P. Koralewski
    M. Blasinska-Morawiec
    R. Deporte-Fety
    E. Chatelut
    F. Leger
    B. Longerey
    L. Ecochard
    I. Douville
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 365 - 373
  • [42] Neutropenic enterocolitis in an advanced epithelial ovarian cancer patient treated with paclitaxel/platinum-based chemotherapy: A case report and review of the literature
    Gadducci, A
    Gargini, A
    Palla, E
    Fanucchi, A
    Genazzani, AR
    ANTICANCER RESEARCH, 2005, 25 (3C) : 2509 - 2513
  • [43] Genomic Predictors of Outcome and Treatment Response in Breast Cancer
    Dunn, Lara
    DeMichele, Angela
    MOLECULAR DIAGNOSIS & THERAPY, 2009, 13 (02) : 73 - 90
  • [44] The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine
    Stovgaard, Elisabeth S.
    Asleh, Karama
    Riaz, Nazia
    Leung, Samuel
    Gao, Dongxia
    Nielsen, Lise B.
    Laenkholm, Anne-Vibeke
    Balslev, Eva
    Jensen, Maj-Britt
    Nielsen, Dorte
    Nielsen, Torsten
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [45] Design, development, and evaluation of docetaxel-loaded niosomes for the treatment of breast cancer
    Dipika S. Gaikwad
    Rutuja D. Chougale
    Kiran S. Patil
    John I. Disouza
    Ashok A. Hajare
    Future Journal of Pharmaceutical Sciences, 9
  • [46] Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study
    Bonneterre, J.
    Campone, M.
    Koralewski, P.
    Blasinska-Morawiec, M.
    Deporte-Fety, R.
    Chatelut, E.
    Leger, F.
    Longerey, B.
    Ecochard, L.
    Douville, I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (03) : 365 - 373
  • [47] Phase II study of gemcitabine and docetaxel in combination for the treatment of metastatic breast cancer
    Goel, Shom
    Abdi, Ehtesham
    Lewis, Craig R.
    Links, Matthew
    Begbie, Steven
    Clingan, Philip
    Ganju, Vinod
    Beith, Jane
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (01) : 32 - 38
  • [48] Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
    Won, Hye Sung
    Kim, Yong Seok
    Kim, Jeong Soo
    Chang, Eun Deok
    Na, Sae Jung
    Whang, In Yong
    Lee, Dong Soo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06) : 1489 - 1496
  • [49] Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy
    Alexandre Chan
    Wing Hang Fu
    Vivianne Shih
    Jurja Chua Coyuco
    Sze Huey Tan
    Raymond Ng
    Supportive Care in Cancer, 2011, 19 : 497 - 504
  • [50] Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy
    Chan, Alexandre
    Fu, Wing Hang
    Shih, Vivianne
    Coyuco, Jurja Chua
    Tan, Sze Huey
    Ng, Raymond
    SUPPORTIVE CARE IN CANCER, 2011, 19 (04) : 497 - 504
12345